FDA Inspection 1141164 — Catalent U.K. Swindon Zydis Limited

Catalent U.K. Swindon Zydis Limited — FEI 3003812585

The FDA completed an inspection of Catalent U.K. Swindon Zydis Limited on February 20, 2020 in Swindon. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
February 20, 2020
Fiscal Year
2020
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Swindon (United Kingdom)

Additional Details

Mutual Recognition Agreement (MRA)